Fundraising FoxRS Research
5 known investors
Find your way into RS Research
Sign up to find every way you can get introduced to RS Research
- Your email: who you already know at RS Research, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the RS Research team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
RS Research develops polymer-drug conjugates for targeted chemotherapy and theranostics in oncology, aiming to improve the therapeutic index in cancer treatment. The company's platform technology addresses the efficacy-toxicity trade-off challenge in targeted therapies.
Founders & leadership
PR
Prof. Rana SanyalCo-Founder
Investors · 5
Also in the syndicate · 4
ACTEczacıbaşı MomentumGEN IlaçleadOneLife Ventures
Funding
SEC filings, press & company announcements- Undisclosed amountSeries ADec 2021
GEN Ilaç (lead), ACT, Eczacıbaşı Momentum, OneLife Ventures
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does RS Research do?
- RS Research develops polymer-drug conjugates for targeted chemotherapy and theranostics in oncology, aiming to improve the therapeutic index in cancer treatment. The company's platform technology addresses the efficacy-toxicity trade-off challenge in targeted therapies.
- Who founded RS Research?
- RS Research was founded by Prof. Rana Sanyal.
- Who are RS Research's investors?
- RS Research's investors include ACT Venture Partners.